


Pharmaceuticals & Biotechnology | Small Cap
SMS Lifesciences India Ltd operates within the Healthcare Services industry. The company demonstrates strong solvency and growth, with excellent scores in these areas. Profitability and coverage ratios are also good, indicating a solid financial standing. However, liquidity and efficiency ratios suggest areas needing attention. The company shows robust growth across revenue, operating profit, EPS, assets and net income. While the company maintains a good balance between debt and equity, its ability to meet short-term obligations and efficiently manage assets could be improved. Overall, SMS Lifesciences exhibits a mixed financial profile, characterized by high growth and profitability but constrained by liquidity and efficiency challenges.
SMS Lifesciences India Ltd operates within the Healthcare Services industry. The company demonstrates strong solvency and growth, with excellent scores in these areas. Profitability and coverage ratios are also good, indicating a solid financial standing. However, liquidity and efficiency ratios suggest areas needing attention. The company shows robust growth across revenue, operating profit, EPS, assets and net income. While the company maintains a good balance between debt and equity, its ability to meet short-term obligations and efficiently manage assets could be improved. Overall, SMS Lifesciences exhibits a mixed financial profile, characterized by high growth and profitability but constrained by liquidity and efficiency challenges.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
23.26
Industry Median
30.92
Small Cap Median
28.82
P/E RATIO
21.63
P/B RATIO
2.11
Industry Median
3.39
Small Cap Median
2.92
P/S RATIO
1.25
Industry Median
3.36
Small Cap Median
2.72
Others
PEG RATIO
1.48
EV/EBITDA RATIO
8.63
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹1438.7 as on Aug 6, 2026.
The growth ratios display a strong upward trend, showing SMS Lifesciences is significantly expanding. High growth in revenue, operating profit, EPS, assets, and net income indicates robust business performance. This growth reflects effective strategies and market positioning. The company is experiencing substantial expansion across various financial metrics. The weighted average calculation underscores the consistent and strong growth trajectory.
| Growth Ratios | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 1.92 | 31.58 | -9.71 | -3.16 | 12.75 |
| Operating Profit Growth Rate | 20 | 16.67 | -17.14 | 6.9 | 45.16 |
| Earnings Per Share (EPS) Growth | 33.2 | 86.73 | -54.73 | -20.68 | 121.22 |
| Asset Growth Rate | N/A | 18.21 | 10.64 | -1.01 | -0.26 |
| Net Income Growth Rate | 40 | 78.57 | -56 | -45.45 | 216.67 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Kilitch Drugs (India) Ltd | 7.12 | 22.83 | Neutral | 37.00 | 9.27 | 30.00 |
| 2 | Medico Remedies Ltd | 6.61 | 37.70 | Overvalued | 17.00 | 1.58 | 13.00 |
| 3 | Kopran Ltd | 6.60 | 25.82 | Neutral | 62.00 | 6.30 | 26.00 |
| 4 | SMS Lifesciences India Ltd | 6.59 | 21.63 | Undervalued | 45.00 | 58.80 | 19.00 |
| 5 | Infinium Pharmachem Ltd | 6.42 | 26.92 | Neutral | 22.00 | 6.43 | 14.00 |
| 6 | Medicamen Biotech Ltd | 5.73 | 33.43 | Neutral | 20.00 | 6.94 | 10.00 |
| 7 | Aarey Drugs & Pharmaceuticals Ltd | 5.73 | 58.43 | Neutral | 7.00 | 1.40 | 4.00 |
| 8 | Albert David Ltd | 5.63 | -279.90 | Neutral | 5.00 | -2.62 | -1.00 |
| 9 | BPL Ltd | 5.46 | -30.53 | Neutral | -4.82 | -1.69 | -8.55 |
| 10 | Zim Laboratories Ltd | 5.41 | 41.96 | Neutral | 30.00 | 1.11 | 6.00 |
| 11 | Lyka Labs Ltd | 4.77 | -26.63 | Neutral | -4.00 | -8.93 | -10.00 |
| 12 | Nectar Lifescience Ltd | 3.83 | -2.67 | Neutral | -59.00 | -2.95 | -293.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish